These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 19706595)

  • 21. Osteocalcin Induces Proliferation via Positive Activation of the PI3K/Akt, P38 MAPK Pathways and Promotes Differentiation Through Activation of the GPRC6A-ERK1/2 Pathway in C2C12 Myoblast Cells.
    Liu S; Gao F; Wen L; Ouyang M; Wang Y; Wang Q; Luo L; Jian Z
    Cell Physiol Biochem; 2017; 43(3):1100-1112. PubMed ID: 28977794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-6 promotes myogenic differentiation of mouse skeletal muscle cells: role of the STAT3 pathway.
    Hoene M; Runge H; Häring HU; Schleicher ED; Weigert C
    Am J Physiol Cell Physiol; 2013 Jan; 304(2):C128-36. PubMed ID: 23114963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ten-Eleven Translocation-2 (Tet2) Is Involved in Myogenic Differentiation of Skeletal Myoblast Cells in Vitro.
    Zhong X; Wang QQ; Li JW; Zhang YM; An XR; Hou J
    Sci Rep; 2017 Mar; 7():43539. PubMed ID: 28272491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mirk/dyrk1B decreases the nuclear accumulation of class II histone deacetylases during skeletal muscle differentiation.
    Deng X; Ewton DZ; Mercer SE; Friedman E
    J Biol Chem; 2005 Feb; 280(6):4894-905. PubMed ID: 15546868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 4-hydroxy-3-methoxy cinnamic acid accelerate myoblasts differentiation on C2C12 mouse skeletal muscle cells via AKT and ERK 1/2 activation.
    Kuppusamy P; Soundharrajan I; Kim DH; Hwang I; Choi KC
    Phytomedicine; 2019 Jul; 60():152873. PubMed ID: 30879871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Akt2 is implicated in skeletal muscle differentiation and specifically binds Prohibitin2/REA.
    Héron-Milhavet L; Mamaeva D; Rochat A; Lamb NJ; Fernandez A
    J Cell Physiol; 2008 Jan; 214(1):158-65. PubMed ID: 17565718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of androgen receptor target genes in skeletal muscle.
    Rana K; Lee NK; Zajac JD; MacLean HE
    Asian J Androl; 2014; 16(5):675-83. PubMed ID: 24713826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of type IV collagen on myogenic characteristics of IGF-I gene-engineered myoblasts.
    Ito A; Yamamoto M; Ikeda K; Sato M; Kawabe Y; Kamihira M
    J Biosci Bioeng; 2015 May; 119(5):596-603. PubMed ID: 25454061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor necrosis factor-alpha and basic fibroblast growth factor differentially inhibit the insulin-like growth factor-I induced expression of myogenin in C2C12 myoblasts.
    Layne MD; Farmer SR
    Exp Cell Res; 1999 May; 249(1):177-87. PubMed ID: 10328964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Permissive roles of phosphatidyl inositol 3-kinase and Akt in skeletal myocyte maturation.
    Wilson EM; Tureckova J; Rotwein P
    Mol Biol Cell; 2004 Feb; 15(2):497-505. PubMed ID: 14595115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ERK2 is required for efficient terminal differentiation of skeletal myoblasts.
    Li J; Johnson SE
    Biochem Biophys Res Commun; 2006 Jul; 345(4):1425-33. PubMed ID: 16729973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. "Spontaneous" differentiation of skeletal myoblasts is dependent upon autocrine secretion of insulin-like growth factor-II.
    Florini JR; Magri KA; Ewton DZ; James PL; Grindstaff K; Rotwein PS
    J Biol Chem; 1991 Aug; 266(24):15917-23. PubMed ID: 1651927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-6 Induces Myogenic Differentiation via JAK2-STAT3 Signaling in Mouse C2C12 Myoblast Cell Line and Primary Human Myoblasts.
    Steyn PJ; Dzobo K; Smith RI; Myburgh KH
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31652937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early-senescent bone marrow mesenchymal stem cells promote C2C12 cell myogenic differentiation by preventing the nuclear translocation of FOXO3.
    Che J; Xu C; Wu Y; Jia P; Han Q; Ma Y; Wang X; Du Y; Zheng Y
    Life Sci; 2021 Jul; 277():119520. PubMed ID: 33887345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IGF-II-mediated downregulation of peroxisome proliferator-activated receptor-γ coactivator-1α in myoblast cells involves PI3K/Akt/FoxO1 signaling pathway.
    Mu X; Qi W; Liu Y; Zhou J; Li Y; Rong X; Lu L
    Mol Cell Biochem; 2017 Aug; 432(1-2):199-208. PubMed ID: 28374141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The insulin-like growth factor-phosphatidylinositol 3-kinase-Akt signaling pathway regulates myogenin expression in normal myogenic cells but not in rhabdomyosarcoma-derived RD cells.
    Xu Q; Wu Z
    J Biol Chem; 2000 Nov; 275(47):36750-7. PubMed ID: 10973962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IGFBP-5 regulates muscle cell differentiation by binding to IGF-II and switching on the IGF-II auto-regulation loop.
    Ren H; Yin P; Duan C
    J Cell Biol; 2008 Sep; 182(5):979-91. PubMed ID: 18762576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p130Cas-dependent actin remodelling regulates myogenic differentiation.
    Kawauchi K; Tan WW; Araki K; Abu Bakar FB; Kim M; Fujita H; Hirata H; Sawada Y
    Biochem J; 2012 Aug; 445(3):323-32. PubMed ID: 22587391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extracellular signal-regulated kinase-1 and -2 respond differently to mitogenic and differentiative signaling pathways in myoblasts.
    Sarbassov DD; Jones LG; Peterson CA
    Mol Endocrinol; 1997 Dec; 11(13):2038-47. PubMed ID: 9415407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth hormone and the insulin-like growth factor system in myogenesis.
    Florini JR; Ewton DZ; Coolican SA
    Endocr Rev; 1996 Oct; 17(5):481-517. PubMed ID: 8897022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.